نتائج البحث

Hematologic Neoplasms Associated with Down Syndrome: Cellular and Molecular Heterogeneity of the Diseases.

• Authors : Peroni E; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, 35128 Padova, Italy.; Gottardi M

Subjects: Down Syndrome*/Down Syndrome*/Down Syndrome*/complications ; Down Syndrome*/Down Syndrome*/Down Syndrome*/genetics ; Down Syndrome*/Down Syndrome*/Down Syndrome*/pathology

• Source: International journal of molecular sciences [Int J Mol Sci] 2023 Oct 18; Vol. 24 (20). Date of Electronic Publication: 2023 Oct 18.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

Recent advances in the roles of exosomal microRNAs (exomiRs) in hematologic neoplasms: pathogenesis, diagnosis, and treatment.

• Authors : Jahromi FNA; Department of Hematology, School of Paramedical, Shiraz University of Medical Sciences, Shiraz, Iran.; Dowran R

Subjects: MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics ; Neoplasms*/Neoplasms*/Neoplasms*/genetics ; Exosomes*/Exosomes*/Exosomes*/metabolism

• Source: Cell communication and signaling : CCS [Cell Commun Signal] 2023 May 01; Vol. 21 (1), pp. 88. Date of Electronic Publication: 2023 May 01.Publisher: BioMed Central Country of Publication: England NLM ID: 101170464 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-811X

تفاصيل العنوان

EBF1, PAX5, and MYC: regulation on B cell development and association with hematologic neoplasms

• Authors : Li Li; Daiquan Zhang; Xinmei Cao

Subjects: EBF1; PAX5; MYC

• Source: Frontiers in Immunology, Vol 15 (2024)

تفاصيل العنوان

Recent advances in the roles of exosomal microRNAs (exomiRs) in hematologic neoplasms: pathogenesis, diagnosis, and treatment

• Authors : Faride Nam Avar Jahromi; Razieh Dowran; Reza Jafari

Subjects: Biomarker; Drug delivery; Hematologic neoplasms

• Source: Cell Communication and Signaling, Vol 21, Iss 1, Pp 1-11 (2023)

تفاصيل العنوان

Participation and Influencing Factors in the Decision-Making of Life-Sustaining Treatment: A Focus on Deceased Patients with Hematologic Neoplasms.

• Authors : Jae Eun Jang¹; Jeong Moon Ryu¹; Min Hee Heo¹

• Source: Journal of Hospice & Palliative Care. Jun2023, Vol. 26 Issue 2, p69-79. 11p.

تفاصيل العنوان

Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapy.

• Authors : Fang HW; Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 123 Ta Pei Road, Kaohsiung, Taiwan.; Tseng PL

Subjects: Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/drug therapy ; Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/prevention & control ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/chemically induced

• Source: Virology journal [Virol J] 2024 Apr 03; Vol. 21 (1), pp. 79. Date of Electronic Publication: 2024 Apr 03.Publisher: BioMed Central Country of Publication: England NLM ID: 101231645 Publication Model: Electronic Cited Medium: Internet ISSN: 1743-422X

تفاصيل العنوان

Mortality in patients with hematological malignancies, febrile neutropenia, and septic shock.

• Authors : Islas-Muñoz B; Infectious Diseases Department, Instituto Nacional de Cancerología (INCan), Alcaldía Tlalpan, 14000 Mexico City.; Volkow-Fernández P

Subjects: Shock, Septic*/Shock, Septic*/Shock, Septic*/epidemiology ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/complications ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/drug therapy

• Source: Journal of infection in developing countries [J Infect Dev Ctries] 2024 Feb 29; Vol. 18 (2), pp. 235-242. Date of Electronic Publication: 2024 Feb 29.Publisher: Open Learning on Enteric Pathogens Country of Publication: Italy NLM ID: 101305410 Publication Model: Electronic Cited Medium: Internet

تفاصيل العنوان

Robot therapy aids mental health in patients with hematological malignancy during hematopoietic stem cell transplantation in a protective isolation unit.

• Authors : Yamada A; Department of Hematology, Tokyo Medical University, 6-7-1, Nishi-Shinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan. .; Akahane D

Subjects: Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/therapy ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/etiology ; Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/adverse effects

• Source: Scientific reports [Sci Rep] 2024 Feb 27; Vol. 14 (1), pp. 4737. Date of Electronic Publication: 2024 Feb 27.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches.

• Authors : Kakavandi S; Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.; Hajikhani B

Subjects: COVID-19* ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/complications ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/epidemiology

• Source: Cell communication and signaling : CCS [Cell Commun Signal] 2024 Feb 15; Vol. 22 (1), pp. 126. Date of Electronic Publication: 2024 Feb 15.Publisher: BioMed Central Country of Publication: England NLM ID: 101170464 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-811X

تفاصيل العنوان

Mucormycosis in children with cancer and hematopoietic cell transplant-A single center cohort study.

• Authors : Marón GA; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.; Department of Pediatrics, University of Tennessee Health Sciences Center, Memphis, Tennessee, United States of America.

Subjects: Mucormycosis*/Mucormycosis*/Mucormycosis*/diagnosis ; Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/adverse effects ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/complications

• Source: PloS one [PLoS One] 2024 Feb 09; Vol. 19 (2), pp. e0297590. Date of Electronic Publication: 2024 Feb 09 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان